Additional information
| Use in sports | None, as it does not enhance athletic performance |
|---|---|
| Formula | C19H16O4 |
| Side effects | Bleeding, bruising, purple toes syndrome, allergic reactions |
| Effects | Reduces blood clot formation |
| Dosage (sports) | Not applicable |
| Dosage (medical) | Typically, the initial dose can vary from 2 to 5 mg per day, adjusted based on INR values |
| Half-life | Approximately 20 to 60 hours |
| Main action | Vitamin K antagonist |
| Substance class | Anticoagulant |
| Chemical name | 3-(О±-Acetonylbenzyl)-4-hydroxycoumarin |
| Water Retention | No water retention effects |
| Storage conditions | Store at room temperature away from moisture and heat |
| Trade name | Coumadin, Jantoven |
| Blood pressure | No direct effect on blood pressure |
| Also known as | Coumadin, Jantoven |
| Strength | 1 mg |
| Lab Test | International Normalized Ratio (INR) tests to monitor blood coagulation levels |
| Hepatotoxicity | Rare liver side effects |
| Manufacturer | Cipla |
Reviews
There are no reviews yet.